Radiopharmaceuticals

Molecular Targeting Technologies
Corporations

MTTI and Brookline Capital Markets Set to Illuminate the Future of Radioisotopes at Boston Summit

- by Timothy Alexander

WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) will collaborate with Brookline Capital Markets at the upcoming 2nd Targeted Radionuclide Pharmaceuticals (TRPs) Supply Chain & Manufacturing Summit in Boston, MA, …

MTTI and Brookline Capital Markets Set to Illuminate the Future of Radioisotopes at Boston Summit Read More

Curadh MTR
Strategic Combinations

NorthStar Medical Radioisotopes and Curadh MTR Forge Alliance to Develop Cancer-Targeting Radiopharmaceuticals

- by Timothy Alexander

CHESTER SPRINGS, PA — NorthStar Medical Radioisotopes, LLC and Curadh MTR Inc. have announced a strategic long-term partnership to develop and produce pioneering radiopharmaceuticals aimed at diagnosing and treating solid …

NorthStar Medical Radioisotopes and Curadh MTR Forge Alliance to Develop Cancer-Targeting Radiopharmaceuticals Read More